Skip to main content
Caplight Logo









NFlection Therapeutics

NFlection Therapeutics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://nflection.com/

Last Round

Debt

Jul 20, 2023

Total Funding Raised

$44M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NFlection Therapeutics is a biopharmaceutical company focused on the discovery and development of targeted topical therapies for rare dermatological disorders driven by aberrant RAS pathway activation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaltopical therapyMEK inhibitordermatologyrare diseasesoft drugdrug discoveryclinical trialneurofibromatosisRAS pathwaytargeted therapybiotech startupskin cancer treatmentdermatological research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NFlection Therapeutics Comparables

Compare NFlection Therapeutics with similar companies based on industry and business-model similarity.

NFlection Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DermBiont
83%
Healx
77%
Nobelpharma Co., Ltd.
77%

NFlection Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 20, 2023
Series BJun 21, 2022
Series AJun 9, 2020

Key People

Founding team and executive leadership

William Hodder

Chief Executive Officer

Executive Team

NFlection Therapeutics Investors

Notable investors and investment history

NFlection Therapeutics investors
InvestorRounds
F-Prime CapitalSeries A
venBioSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors grew 60% MoM.

  • Jun 21, 2022

    $20M round led by Children's Tumor Foundation.

NFlection Therapeutics Filings

Explore SEC and related filing metadata, where available.

NFlection Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NFlection Therapeutics's valuation, stock price, and market status.

Is NFlection Therapeutics a public or private company?

NFlection Therapeutics is a private company.

What is the current stock price of NFlection Therapeutics?

NFlection Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is NFlection Therapeutics worth (valuation)?

Valuation information for NFlection Therapeutics is not publicly available.

Can I buy NFlection Therapeutics stock?

NFlection Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NFlection Therapeutics's last funding round?

NFlection Therapeutics's most recent funding round was Debt on July 20, 2023.

Who are the main investors in NFlection Therapeutics?

Key investors in NFlection Therapeutics include F-Prime Capital, venBio.

Will NFlection Therapeutics IPO soon?

No public IPO plans have been announced for NFlection Therapeutics.

How can I track NFlection Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NFlection Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range9
Year Founded2013
Last FundingJul 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?